Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
Dongwook Oh, Jung‐Soo Pyo, Byoung Kwan Son
Gastroenterology Research and Practice (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis
Ke Zhou, Jie Cao, Huahang Lin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 35
The Value of Platelet-to-Lymphocyte Ratio as a Prognostic Marker in Cholangiocarcinoma: A Systematic Review and Meta-Analysis
Dong Liu, Zoltán Czigány, Lara R. Heij, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 438-438
Open Access | Times Cited: 28
Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Huilin Xu, Anbing He, Aihua Liu, et al.
International Immunopharmacology (2019) Vol. 77, pp. 105957-105957
Open Access | Times Cited: 42
Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis
Liwei Ni, Jialong Tao, Jianhao Xu, et al.
Archives of Gynecology and Obstetrics (2019) Vol. 301, Iss. 1, pp. 251-261
Open Access | Times Cited: 42
Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
İbrahim Mungan, Çilem Bayındır Dicle, Şerife Gökbulut Bektaş, et al.
Military Medical Research (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 39
The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer
Marta Toledano‐Fonseca, María Teresa Cano, Elizabeth Inga, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1210-1210
Open Access | Times Cited: 28
Inflammatory Markers in Predicting Survival in Pancreatic Cancer: A Systematic Review and Meta-analysis
Rinrada Worapongpaiboon, Noppachai Siranart, Patavee Pajareya, et al.
Pancreatology (2025)
Closed Access
The role of systemic immuno-inflammatory factors in resectable pancreatic adenocarcinoma: a cohort retrospective study
Diana Schlanger, Călin Popa, Sergiu P. Paşca, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma
Kosuke Yoshida, Nobuhisa Yoshikawa, Akira Shirakawa, et al.
Journal of Gynecologic Oncology (2019) Vol. 30, Iss. 6
Open Access | Times Cited: 24
Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study
Masami Miki, Nao Fujimori, Keijiro Ueda, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5084-5084
Open Access | Times Cited: 14
Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study
Bianca Varzaru, Răzvan Iacob, Ștefania Bunduc, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2854-2854
Open Access | Times Cited: 2
Prognostic Impact of the Neutrophil‐to‐Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection
Hirokazu Kubo, Takashi Murakami, Ryusei Matsuyama, et al.
World Journal of Surgery (2019) Vol. 43, Iss. 12, pp. 3153-3160
Closed Access | Times Cited: 18
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma
Paul McLellan, Julie Henriques, Feryel Letaief Ksontini, et al.
Clinics and Research in Hepatology and Gastroenterology (2020) Vol. 45, Iss. 3, pp. 101541-101541
Open Access | Times Cited: 17
Loss of adipose tissue or skeletal muscle during first‐line gemcitabine/nab‐paclitaxel therapy is associated with worse survival after second‐line therapy of advanced pancreatic cancer
Masami Miki, Lingaku Lee, Terumasa Hisano, et al.
Asia-Pacific Journal of Clinical Oncology (2021) Vol. 18, Iss. 5
Open Access | Times Cited: 11
Low preoperative psoas muscle mass index is a risk factor for distal cholangiocarcinoma recurrence after pancreatoduodenectomy: a retrospective analysis
Saori Umezawa, Shinjiro Kobayashi, Takehito Otsubo
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 8
A clinical research on the potential pathogenesis of somatic cancer related cerebral venous sinus thrombosis
Ziqiang Xian, Yicong Chen, Li Chen, et al.
Medicine (2019) Vol. 98, Iss. 19, pp. e15134-e15134
Open Access | Times Cited: 12
Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients
Fengming Ji, Qiang Kang, Lianmin Wang, et al.
Medicine (2020) Vol. 99, Iss. 43, pp. e22827-e22827
Open Access | Times Cited: 11
Circulating tumor DNA: a help to guide therapeutic strategy in patients with borderline and locally advanced pancreatic adenocarcinoma?
Olivier Caliez, Daniel Pietrasz, Feryel Letaief Ksontini, et al.
Digestive and Liver Disease (2022) Vol. 54, Iss. 10, pp. 1428-1436
Open Access | Times Cited: 7
Initial platelet-to-lymphocyte count as prognostic factor in limited-stage small cell lung cancer
Qing Zhang, Yanli Qu, Hangyu Liu, et al.
Biomarkers in Medicine (2019) Vol. 13, Iss. 4, pp. 249-258
Closed Access | Times Cited: 8
Platelet-to-lymphocyte ratio and CA19-9 are simple and informative prognostic factors in patients with resected pancreatic cancer
Ionuţ Negoi, Mircea Beuran, Sorin Hostiuc, et al.
Hepatobiliary & pancreatic diseases international (2019) Vol. 18, Iss. 3, pp. 203-205
Open Access | Times Cited: 7
A Systematic Inflammation-based Model in Advanced Pancreatic Ductal Adenocarcinoma
Lixia Wu, Xiaoyong Wang, Kequn Xu, et al.
Journal of Cancer (2019) Vol. 10, Iss. 26, pp. 6673-6680
Open Access | Times Cited: 7
A hierarchical prognostic model for Co-diabetes pancreatic adenocarcinoma
Zelong Wu, Chunsheng Liu, Zuyi Ma, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21642-e21642
Open Access | Times Cited: 2
Peripheral Blood Cell Variables Related to Systemic Inflammation in Patients With Unresectable or Metastatic Pancreatic Cancer
Giuseppe Colloca, Antonella Venturino
Pancreas (2021) Vol. 50, Iss. 8, pp. 1131-1136
Closed Access | Times Cited: 5
Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma
James S. Strong, Elvira L. Vos, Caitlin A. McIntyre, et al.
The American Surgeon (2021) Vol. 88, Iss. 6, pp. 1153-1158
Open Access | Times Cited: 4
Usefulness of Inflammation-Based Prognostic Scores in Patients with Surgically Treated Pancreatic Ductal Adenocarcinoma
Sarang Hong, Dae Wook Hwang, Jae Hoon Lee, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5784-5784
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top